Cargando…

Glucokinase Activators for Diabetes Therapy: May 2010 status report

Detalles Bibliográficos
Autores principales:	Matschinsky, Franz M., Zelent, Bogumil, Doliba, Nicolai, Li, Changhong, Vanderkooi, Jane M., Naji, Ali, Sarabu, Ramakanth, Grimsby, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes Treatments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632186/ https://www.ncbi.nlm.nih.gov/pubmed/21525462 http://dx.doi.org/10.2337/dc11-s236

Ejemplares similares

Ebb and Tide of Glucokinase
por: Matschinsky, Franz M.
Publicado: (2001)

Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor
por: Doliba, Nicolai M., et al.
Publicado: (2017)

Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics
por: Matschinsky, Franz M, et al.
Publicado: (2010)

Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations
por: Sayed, Samir, et al.
Publicado: (2009)

Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
por: Cuesta-Muñoz, Antonio L., et al.
Publicado: (2010)

Susceptibility of Glucokinase-MODY Mutants to Inactivation by Oxidative Stress in Pancreatic β-Cells
por: Cullen, Kirsty S., et al.
Publicado: (2011)

Accumulation of 3-hydroxytetradecenoic acid: Cause or corollary of glucolipotoxic impairment of pancreatic β-cell bioenergetics?
por: Doliba, Nicolai M., et al.
Publicado: (2015)

The Central Role of Glucokinase in Glucose Homeostasis: A Perspective 50 Years After Demonstrating the Presence of the Enzyme in Islets of Langerhans
por: Matschinsky, Franz M., et al.
Publicado: (2019)

Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations
por: Li, Changhong, et al.
Publicado: (2023)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts
por: Tuomilehto, Jaakko, et al.
Publicado: (2011)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2011)

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
por: Lebovitz, Harold E.
Publicado: (2011)

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
por: Miccoli, Roberto, et al.
Publicado: (2011)

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective
por: Garber, Alan J.
Publicado: (2011)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists
por: Sesti, Giorgio
Publicado: (2011)

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
por: Dicker, Dror
Publicado: (2011)

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
por: Garber, Alan J.
Publicado: (2011)

An Outline of the Allen Method
Publicado: (1919)

Analysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescence
por: Zelent, Bogumil, et al.
Publicado: (2014)

Alterations of Pancreatic Islet Structure, Metabolism and Gene Expression in Diet-Induced Obese C57BL/6J Mice
por: Roat, Regan, et al.
Publicado: (2014)

SAT163 Title: Adult-onset Hyperinsulinemic Hypoglycemia Due To An Activating Mutation In Glucokinase
por: Vaid, Sonal, et al.
Publicado: (2023)

MON-666 Glucokinase Within the Hypothalamic Paraventricular Nucleus Is Important in GLP-1 Release
por: Ratnasabapathy, Risheka
Publicado: (2020)

Role of Glucokinase in the Subcellular Localization of Glucokinase Regulatory Protein
por: Jin, Ling, et al.
Publicado: (2015)

Present status of clinical deployment of glucokinase activators
por: Nakamura, Akinobu, et al.
Publicado: (2015)

Cases Which May Benefit from Surgical Measures
Publicado: (1919)

Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis
por: Gehin, Johanna Elin, et al.
Publicado: (2021)

Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
por: Husain, Muhammad Jami, et al.
Publicado: (2019)

Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation?
por: Thompson, David R, et al.
Publicado: (2022)

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)
por: Vakil, Deep, et al.
Publicado: (2021)

Dental management of patients with substance use disorder
por: Cuberos, Mara, et al.
Publicado: (2020)

The effectiveness of an attention‐based intervention for school‐aged autistic children with anger regulating problems: A randomized controlled trial
por: Clifford, Pamela, et al.
Publicado: (2022)

Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis
por: Aeberli, Daniel, et al.
Publicado: (2016)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation
por: Butink, Maarten H P, et al.
Publicado: (2023)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Cardiac Sarcoidosis: When and How to Treat Inflammation
por: Giblin, Gerard T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kloc29dfj1h03qh47hdaek11um